Literature DB >> 8702726

Molecular basis of canine muscle type phosphofructokinase deficiency.

B F Smith1, H Stedman, Y Rajpurohit, P S Henthorn, J H Wolfe, D F Patterson, U Giger.   

Abstract

Muscle type phosphofructokinase (M-PFK) deficiency is a rare inherited glycogen storage disease in humans that causes exertional myopathy and hemolysis. The molecular basis of canine M-PFK deficiency, the only naturally occurring animal homologue, was investigated. Lack of M-PFK enzyme activity was caused by a nonsense mutation in the penultimate exon of the M-PFK gene, leading to rapid degradation of a truncated (40 amino acids) and therefore unstable M-PFK protein. A polymerase chain reaction-based test was devised to identify M-PFK-deficient and carrier animals. This represents one of only a few inborn errors of metabolism where the molecular defect has been identified in a large animal model which can now be used to develop and assess novel therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8702726     DOI: 10.1074/jbc.271.33.20070

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

Review 1.  Semper fidelis: what man's best friend can teach us about human biology and disease.

Authors:  E A Ostrander; E Giniger
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

2.  Missense mutation in PFKM associated with muscle-type phosphofructokinase deficiency in the Wachtelhund dog.

Authors:  G Inal Gultekin; K Raj; S Lehman; A Hillström; U Giger
Journal:  Mol Cell Probes       Date:  2012-03-16       Impact factor: 2.365

3.  Erythrocytic pyruvate kinase mutations causing hemolytic anemia, osteosclerosis, and seconday hemochromatosis in dogs.

Authors:  G Inal Gultekin; K Raj; P Foureman; S Lehman; K Manhart; O Abdulmalik; U Giger
Journal:  J Vet Intern Med       Date:  2012 Jul-Aug       Impact factor: 3.333

Review 4.  Skeletal muscle disorders of glycogenolysis and glycolysis.

Authors:  Richard Godfrey; Ros Quinlivan
Journal:  Nat Rev Neurol       Date:  2016-05-27       Impact factor: 42.937

5.  Hereditary phosphofructokinase deficiency in wachtelhunds.

Authors:  Anna Hillström; Harold Tvedten; André Rowe; Urs Giger
Journal:  J Am Anim Hosp Assoc       Date:  2011-02-10       Impact factor: 1.023

Review 6.  Preclinical Development of New Therapy for Glycogen Storage Diseases.

Authors:  Baodong Sun; Elizabeth D Brooks; Dwight D Koeberl
Journal:  Curr Gene Ther       Date:  2015       Impact factor: 4.391

7.  Hemolysis, myopathy, and cardiac disease associated with hereditary phosphofructokinase deficiency in two Whippets.

Authors:  Karen Gerber; John W Harvey; Sara D'Agorne; Jonathan Wood; Urs Giger
Journal:  Vet Clin Pathol       Date:  2008-10-28       Impact factor: 1.180

Review 8.  Changing paradigms in diagnosis of inherited defects associated with urolithiasis.

Authors:  Danika Bannasch; Paula S Henthorn
Journal:  Vet Clin North Am Small Anim Pract       Date:  2009-01       Impact factor: 2.093

Review 9.  Large animal models and new therapies for glycogen storage disease.

Authors:  Elizabeth D Brooks; Dwight D Koeberl
Journal:  J Inherit Metab Dis       Date:  2014-09-16       Impact factor: 4.982

10.  Frequency of five disease-causing genetic mutations in a large mixed-breed dog population (2011-2012).

Authors:  Sharon Zierath; Angela M Hughes; Neale Fretwell; Mark Dibley; Kari J Ekenstedt
Journal:  PLoS One       Date:  2017-11-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.